JCIC Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-800
| Closed | -$22.4K | – | 107 |
|
|
2024
Q2 | $22.4K | Hold |
800
| – | – | 0.01% | 82 |
|
|
2024
Q1 | $22.2K | Hold |
800
| – | – | 0.01% | 85 |
|
|
2023
Q4 | $23K | Buy |
+800
| New | +$24.2K | 0.01% | 83 |
|
|
2022
Q3 | – | Sell |
-85,788
| Closed | -$4.5M | – | 118 |
|
|
2022
Q2 | $4.5M | Sell |
85,788
-10,375
| -11% | -$529K | 2.42% | 18 |
|
|
2022
Q1 | $4.98M | Sell |
96,163
-1,457
| -1% | -$75.6K | 1.54% | 29 |
|
|
2021
Q4 | $5.76M | Sell |
97,620
-270
| -0.3% | -$13.4K | 1.73% | 23 |
|
|
2021
Q3 | $4.21M | Sell |
97,890
-1,815
| -2% | -$80.4K | 1.38% | 29 |
|
|
2021
Q2 | $4.84M | Sell |
99,705
-2,425
| -2% | -$94.3K | 1.25% | 32 |
|
|
2021
Q1 | $3.7M | Buy |
102,130
+106
| +0.1% | +$3.76K | 1.3% | 32 |
|
|
2020
Q4 | $3.76M | Sell |
102,024
-3,391
| -3% | -$124K | 1.51% | 26 |
|
|
2020
Q3 | $3.67M | Buy |
105,415
+1,959
| +2% | +$68.7K | 1.7% | 23 |
|
|
2020
Q2 | $3.21M | Buy |
103,456
+5,470
| +6% | +$186K | 1.65% | 23 |
|
|
2020
Q1 | $3.03M | Sell |
97,986
-45,371
| -32% | -$1.55M | 1.88% | 24 |
|
|
2019
Q4 | $5.33M | Sell |
143,357
-3,515
| -2% | -$125K | 2.06% | 21 |
|
|
2019
Q3 | $5.01M | Sell |
146,872
-3,552
| -2% | -$129K | 2.2% | 20 |
|
|
2019
Q2 | $6.18M | Buy |
150,424
+454
| +0.3% | +$18K | 2.56% | 17 |
|
|
2019
Q1 | $6.04M | Sell |
149,970
-140,984
| -48% | -$5.65M | 2.4% | 18 |
|
|
2018
Q4 | $12M | Sell |
290,954
-606
| -0.2% | -$25.2K | 5.34% | 3 |
|
|
2018
Q3 | $12.2M | Buy |
291,560
+29,665
| +11% | +$1.14M | 4.2% | 5 |
|
|
2018
Q2 | $9.02M | Sell |
261,895
-2,248
| -0.9% | -$76.8K | 3.06% | 11 |
|
|
2018
Q1 | $8.89M | Buy |
264,143
+3,895
| +1% | +$134K | 2.95% | 11 |
|
|
2017
Q4 | $8.94M | Sell |
260,248
-16,053
| -6% | -$547K | 2.94% | 11 |
|
|
2017
Q3 | $9.36M | Sell |
276,301
-4,590
| -2% | -$148K | 3.19% | 12 |
|
|
2017
Q2 | $8.95M | Buy |
280,891
+3,468
| +1% | +$109K | 3.08% | 11 |
|
|
2017
Q1 | $9M | Sell |
277,423
-14,008
| -5% | -$442K | 3.16% | 12 |
|
|
2016
Q4 | $8.98M | Sell |
291,431
-46,555
| -14% | -$1.42M | 3.04% | 16 |
|
|
2016
Q3 | $10.9M | Sell |
337,986
-26,187
| -7% | -$876K | 3.42% | 14 |
|
|
2016
Q2 | $12.2M | Sell |
364,173
-23,399
| -6% | -$747K | 3.63% | 14 |
|
|
2016
Q1 | $10.9M | Sell |
387,572
-12,237
| -3% | -$350K | 3.02% | 19 |
|
|
2015
Q4 | $12.2M | Sell |
399,809
-256,204
| -39% | -$8.06M | 3.37% | 13 |
|
|
2015
Q3 | $19.6M | Sell |
656,013
-64,098
| -9% | -$2.06M | 4.81% | 5 |
|
|
2015
Q2 | $22.9M | Sell |
720,111
-17,380
| -2% | -$566K | 4.11% | 6 |
|
|
2015
Q1 | $24.3M | Sell |
737,491
-7,355
| -1% | -$234K | 4.4% | 6 |
|
|
2014
Q4 | $22M | Buy |
744,846
+9,549
| +1% | +$274K | 4.48% | 6 |
|
|
2014
Q3 | $20.6M | Sell |
735,297
-3,262
| -0.4% | -$91.6K | 3.86% | 9 |
|
|
2014
Q2 | $20.8M | Buy |
738,559
+31,910
| +5% | +$910K | 3.48% | 11 |
|
|
2014
Q1 | $21.5M | Buy |
706,649
+700,852
| +12,090% | +$20.9M | 3.93% | 11 |
|
|
2013
Q4 | $168K | Hold |
5,797
| – | – | 0.03% | 40 |
|
|
2013
Q3 | $158K | Hold |
5,797
| – | – | 0.03% | 44 |
|
|
2013
Q2 | $154K | Buy |
+5,797
| New | +$160K | 0.03% | 45 |
|
Other funds holding PFE
JCIC Asset Management's PFE Position: Q3 2024 in Review
JCIC Asset Management sold out of Pfizer (PFE) in Q3 2024, closing a stake of 800 shares — an estimated $22.4K sold.
JCIC Asset Management first reported a position in PFE in Q2 2013 and held it in 40 quarters. The position peaked at $24.3M in Q1 2015. 2,909 funds tracked by Wall St. Rank hold PFE as of Q3 2024.
- JCIC Asset Management reported no remaining Pfizer position as of Q3 2024 after selling out during the quarter.
- JCIC Asset Management sold 800 Pfizer shares in Q3 2024, an estimated $22.4K.
- JCIC Asset Management first reported a position in Pfizer in Q2 2013 and held it in 40 quarters.
- JCIC Asset Management's Pfizer position peaked at $24.3M in Q1 2015.
- 2,909 funds tracked by Wall St. Rank held Pfizer as of Q3 2024.
Based on JCIC Asset Management's 13F filing for Q3 2024, filed 22 Oct 2024.